Risk factors of diffuse alveolar hemorrhage after acute ischemic stroke treated with tissue-type plasminogen activator. The effectiveness of activated recombinant factor VII treatment.

Shimizu, Yu; Tsuchiya, Katsuhiro; Fujisawa, Norihiro

Shimizu, Yu; Tsuchiya, Katsuhiro; Fujisawa, Norihiro.

Afiliación

Shimizu Y; Department of Neurosurgery, Kanazawa Medical Center, Shimoishibikimachi, Kanazawa, Ishikawa, Japan.
Tsuchiya K; Department of Neurosurgery, Kanazawa Medical Center, Shimoishibikimachi, Kanazawa, Ishikawa, Japan.
Fujisawa N; Department of Neurosurgery, Kanazawa Medical Center, Shimoishibikimachi, Kanazawa, Ishikawa, Japan.

Surg Neurol Int ; 11: 129, 2020.

Article en En | MEDLINE | ID: mdl-32547816

Palabras clave

Activated recombinant factor VII; Acute ischemic stroke; Diffuse alveolar hemorrhage; National Institutes of Health Stroke Scale; Tissue-type plasminogen activator

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Surg Neurol Int Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google